Chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with CKD stage G3b-4 (eGFR 15-<45ml/min/1.73m2) aged 18 years or older who have given written consent to participate in this study and to receive online medical assistance, and family doctors that have agreed to participate in this study
Exclusion criteria
Exclusion criteria: 1) Patients with suspected rapid progressive glomerulonephritis syndrome 2) Patients with suspected nephrotic syndrome 3) Heart failure (NYHA 3and 4) 4) Poorly controlled hypertension (systolic blood pressure 180mmHg or more, diastolic blood pressure 110mmHg or more) 5) Patients whose participation in this study is deemed inappropriate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Prognosis of renal function during the 2-year observation period 2) Patient and institution characteristics in face-to-face care and online medical assistance care | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Assessment of institutional and patient satisfaction using questionnaires 2) Expanded MACE (non-fatal myocardial infarction and stroke, cardiovascular death, heart failure for hospitalization, unstable angina, percutaneous coronary intervention)during the 2-year observation period 3) Number of online medical assistance, number of visits to family doctors, and number of visits to nephrologists during the observation period | — |
Countries
Japan
Contacts
Osaka General Medical Center Department of Kidney Disease and Hypertension